Active — Not RecruitingNot Applicable

Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia

Pakistan122 participantsStarted 2025-05-20

Plain-language summary

In this Study investigator is comparing the effectiveness and outcomes of two drugs used un the treatment of trigeminal neuralgia , Carbamazepine vs Oxcarbazepine

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Inclusion Criteria: * Age 18-60 years * Either gender * TGN diagnosis for ≥2 weeks (according to ICHD-3 criteria¹) Exclusion Criteria \[Expanded\]: * Other cranial neuralgias * Prior surgical treatment for TN * Hepatic/renal dysfunction * Epilepsy * Pregnant/lactating women * Drug allergy or intolerance * \[Expanded\] Uncontrolled hypertension * \[Expanded\] Psychiatric disorders

What they're measuring

Pain relief for TGN

Timeframe: Two months

Trial details

NCT IDNCT07252453

SponsorAbbasi Shaheed Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-20

View on ClinicalTrials.gov More Trigeminal Neuralgia trials